Abstract:A series of ruthenium(II) complexes containing andrographolide‐based hydrazide derivatives were synthesized and characterized. The anticancer nature of the synthesized compounds has examined with MTT assay, staining assays, and flow cytometry analysis. All the ligands and complexes showed potent anticancer activity. A new set of andrographolide‐appended hydrazide derivatives (AFC, AGC, and ATC) were prepared from the reaction of andrographolide with furan‐2‐carboxylic acid hydrazide (AFC), pyridine‐3‐carboxylic acid hydrazide (AGC), and thiophene 2‐carboxylic acid hydrazide (ATC), and their corresponding ruthenium(II) complexes (Ru‐AFC, Ru‐AGC, and Ru‐ATC) were synthesized by the direct reaction of [RuCl2(η6‐p‐cymene)]2 with ligands in dichloromethane under stirring condition. The compounds were analyzed by elemental analysis, IR, UV‐Vis, 1H NMR, and ESI‐MS spectrometric techniques, and the obtained spectral data revealed that the ligands coordinated to Ru(II) ion through their enone oxygen and amine nitrogen. Antioxidant activities of the ligands and complexes were calculated against DPPH•, ABTS•+, O2−, and NO• free radicals and their results were compared with standard antioxidants. The cytotoxic activity of the synthesized ligands and complexes toward A549 and HeLa cell lines was evaluated using MTT method (MTT = 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide). Among the compounds, the complex Ru‐AGC showed better cytotoxic effect against A549 and HeLa cancer cells with IC50 values of 4.75 ± 0.17 and 6.32 ± 0.26 μM, respectively. Further, the nontoxic nature of the compounds was confirmed by using human umbilical vein endothelial (HUVEC) cells. The apoptosis was inspected with AO/EB and DAPI staining methods; further, the percentages of the apoptotic and necrotic cells were determined by flow cytometry. Overall, the biological activities of our ruthenium(II)‐arene complexes were found to be more potent than their parent ligands due to chelation, and among the complexes, Ru‐AGC showed better activity due to the presence of pyridine ring in the N‐terminal position of the ligand. The obtained results highlighted the strong possibility to develop highly active ruthenium complexes as anticancer agents.

Biological evaluation of ruthenium(II) complexes appended curcumin derivatives: Synthesis, spectral characterization, anti-oxidant and anti-cancer studies

Ruthenium(II) Arene Complexes of Curcuminoids: Synthesis, X-ray Diffraction Structure and Cytotoxicity

Bifunctional Ruthenium(ii) Polypyridyl Complexes of Curcumin As Potential Anticancer Agents

Ruthenium(II) complexes of curcumin and β-diketone derivatives: effect of structural modifications on their cytotoxicity

Synthesis, Characterization and Anticancer Activity of A Series of Curcuminoids and Their Half-Sandwich Ruthenium(Ii) Complexes

Dinuclear arene ruthenium(II) arylthiourea complexes: Synthesis, structure, cancer cell growth inhibition and apoptosis induction studies

Ruthenium(II)-curcumin liposome nanoparticles: Synthesis, characterization, and their effects against cervical cancer

Selective anticancer activities of ruthenium(II)-tetrazole complexes and their mechanistic insights

Ruthenium(III) S-methylisothiosemicarbazone Schiff base complexes bearing PPh3/AsPh3 coligand: synthesis, structure and biological investigations, including antioxidant, DNA and protein interaction, and in vitro anticancer activities.

Biomolecular Interactions and Anticancer Mechanisms of Ru(II)-Arene Complexes of Cinnamaldehyde-Derived Thiosemicarbazone Ligands: Analysis Combining In Silico and In Vitro Approaches

Ru(II)‐Nitrophenylhydrazine/Chlorophenylhydrazine Complexes: Nanoarchitectonics, Biological Evaluation and In silico Study

Exploring the Cytotoxicity of Dinuclear Ru(II) p-cymene Complexes Appended N,N'-Bis(4-substituted benzoyl)hydrazines: Insights into the Mechanism of Apoptotic Cell Death

Synthesis, Characterization, Cytotoxic Activity of Half-Sandwich Rhodium(iii), and Iridium(iii) Complexes with Curcuminoids

Synthesis, spectral characterization and biological evaluation of diosgenin coordinated ruthenium-arene complexes

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (poly)cyclic Aromatic Diamine Ligands.

Synthesis, Crystal and Electronic Structure, Anticancer Activity of Ruthenium(Ii) Arene Complexes with Thiosemicarbazones

New Organoruthenium(II) Complexes Containing Andrographolide‐Appended Hydrazide Derivatives: Synthesis, Spectral Characterization, Anticancer Evaluation

Synthesis, characterization and anticancer activity of dinuclear ruthenium(II) complexes linked by an alkyl chain

Synthesis, characterization, and antitumor activity of mononuclear and dinuclear ruthenium complexes

Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex.

Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes